• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, July 4, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

Complete clearance of hepatitis B is rare — especially in women…

Bioengineer.org by Bioengineer.org
January 26, 2018
in Headlines, Health, Science News
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

hepatitis-b

Researchers at several different US sites have found that less than one-third of 1% of patients infected with hepatitis B virus (HBV) get rid of the virus per year, and overall, only 1.2% of patients finally get rid of it.

Men were twice as likely as women to clear the virus completely. People of Asian descent were less likely than other racial or ethnic groups to clear the virus. People over the age of 45 were almost twice as likely to get rid of the virus as younger patients.

HBV infection is extremely common, affecting approximately 250 million people worldwide, and it can lead to liver cirrhosis and liver cancer.

“We felt it was important to highlight just how rarely this highly desirable outcome called seroclearance occurs in what we believe to be the largest North American study of its kind,” said Dr. Long Nguyen, lead author of the Alimentary Pharmacology & Therapeutics analysis. ”

“This is further proof that our current standard therapies — for which viral suppression rather than elimination are the goal — may not suffice and that more research should be dedicated to therapeutics that help achieve viral cure,” added senior author Dr. Mindie Nguyen

###

Media Contact

Penny Smith
[email protected]

http://www.wiley.com/wiley-blackwell

Photo Credit: Punch Newspaper,Dated March 5,2012

Share14Tweet9Share2ShareShareShare2

Related Posts

Steatosis Drives Liver Metastasis Diversity in CRC — Medicine

Steatosis Drives Liver Metastasis Diversity in CRC

July 2, 2026

Unlocking the Mysteries of Alzheimer’s Disease

July 2, 2026

Pensoft Introduces New Peer-Reviewed Journal of Regeneration to Advance Restorative Biology Across Species

July 2, 2026

Evolution-Inspired Biosensors Revolutionize Lipid Tracking in Real Time

July 2, 2026
Please login to join discussion

POPULAR NEWS

  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • KTU Researchers Explore Ultrasound’s Role in Enhancing Blood Flow Beyond Diagnostics

    53 shares
    Share 21 Tweet 13

About

BIOENGINEER.ORG

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Steatosis Drives Liver Metastasis Diversity in CRC

Unlocking the Mysteries of Alzheimer’s Disease

Pensoft Introduces New Peer-Reviewed Journal of Regeneration to Advance Restorative Biology Across Species

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 83 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.